News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
JD HEALTH Plans Up to USD1B Share Buyback
JD HEALTH (06618.HK) announced that the Board has authorized and approved a program to repurchase up to USD1 billion in value of the shares of the Company from the open market over...
Reset
Send
The window will close in 5 seconds
JD HEALTH Plans Up to USD1B Share Buyback
Close
Recommend
11
Positive
19
Negative
9
 
 

JD HEALTH (06618.HK)  -0.500 (-1.023%)    Short selling $211.06M; Ratio 29.168%   announced that the Board has authorized and approved a program to repurchase up to USD1 billion in value of the shares of the Company from the open market over a 48-month period starting from the approval date.

The Board believed that the Proposed Share Repurchase in the present conditions will demonstrate the Company’s confidence in its current and long-term business outlook and prospects, and that the current financial resources of the Company would enable it to implement the Proposed Share Repurchase while maintaining a solid financial position.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-14 16:25.)

Related NewsJD HEALTH (06618.HK) 1Q26 Non-IFRS Net Profit Up 6% YoY to RMB1.874B

Auto-translated by AI
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.